Advertisement

European Archives of Paediatric Dentistry

, Volume 17, Issue 3, pp 195–203 | Cite as

Dental treatment for people with cystic fibrosis

  • N. HarringtonEmail author
  • P. J. Barry
  • S. M. Barry
Original Scientific Article

Abstract

Aim

To describe the nature and consequences of the multi-system genetic condition cystic fibrosis with a view to ensuring optimal dental treatment planning for these patients.

Methods

A literature search was conducted to identify the key medical and dental manifestations of cystic fibrosis. These findings are discussed and utilised to create recommendations for treatment planning in patients with cystic fibrosis for the practising dental practitioner.

Results

Cystic fibrosis is a complex, lethal, multisystem autosomal recessive disorder resulting from mutations on chromosome 7 which result in dysfunction of an ion channel that sits on epithelial surfaces. Respiratory disease remains the leading cause of mortality. Survival has greatly increased in recent decades secondary to improved treatment and specialist care. Specific dental manifestations of the disease may result from the condition itself or complications of treatment. Modification of patient management may be necessary to provide optimum patient care.

Conclusion

The pathophysiology and clinical manifestations are relevant to practicing dental practitioners and inform recommendations to be utilised to ensure optimal treatment planning for these patients.

Keywords

Cystic fibrosis Caries Respiratory Dental 

Notes

Acknowledgments

The authors would like to acknowledge the kind contribution of the clinical image by Dr. Rowland Bright-Thomas, Manchester Adult CF Centre.

Compliance with Ethical Standards

Conflict of interest

PB has received honoraria and financial support for educational activities from Vertex pharmaceuticals Ltd.

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. Alton EW, Armstrong DK, Ashby D, et al. Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir Med. 2015;3:684–91.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Andersen DH. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study. Am J Dis Child. 1938;56:344.CrossRefGoogle Scholar
  3. Aps JK, Van Maele GO, Claeys G, Martens LC. Mutans streptococci, lactobacilli and caries experience in cystic fibrosis homozygotes, heterozygotes and healthy controls. Caries Res. 2001;35:407–11.CrossRefPubMedGoogle Scholar
  4. Azevedo TDPL, Feijó GCS, Bezerra ACB. Presence of developmental defects of enamel in cystic fibrosis patients. J Dent Child. 2006;73:159–63.Google Scholar
  5. Balfour-Lynn IM, Welch K. Inhaled corticosteroids for cystic fibrosis. Cochrane Database Syst Rev. 2014. doi: 10.1002/14651858.CD001915.pub4.
  6. Barry PJ, Ronan N, Plant BJ. Cystic fibrosis transmembrane conductance regulator modulators: the end of the beginning. Semin Respir Crit Care Med. 2015;36:287–98.CrossRefPubMedGoogle Scholar
  7. Barry S, Fleming P, O’Connor M. Prescribing sugar-containing medicines for children—are we forgetting “primum non nocere?” Ir Med J. 2009;102:298–300.PubMedGoogle Scholar
  8. Bear CE, Li CH, Kartner N, et al. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell. 1992;68:809–18.CrossRefPubMedGoogle Scholar
  9. Blacharsh C. Dental aspects of patients with cystic fibrosis: a preliminary clinical study. J Am Dent Assoc. 1977;95:106–10.CrossRefPubMedGoogle Scholar
  10. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2002;35:246–59.CrossRefPubMedGoogle Scholar
  11. Brennan AL, Beynon J. Clinical updates in cystic fibrosis-related diabetes. Semin Respir Crit Care Med. 2015;36:236–50.CrossRefPubMedGoogle Scholar
  12. Brihaye P, Jorissen M, Clement PA. Chronic rhinosinusitis in cystic fibrosis (mucoviscidosis). Acta Otorhinolaryngol. 1997;51:323–37.Google Scholar
  13. Chi DL. Dental caries prevalence in children and adolescents with cystic fibrosis: a qualitative systematic review and recommendations for future research. Int J Paediatr Dent. 2013;23(5):376–86.CrossRefPubMedPubMedCentralGoogle Scholar
  14. Colombo C. Liver disease in cystic fibrosis. Curr Opin Pulm Med. 2007;13:529–36.CrossRefPubMedGoogle Scholar
  15. Conwell LS, Chang AB. Bisphosphonates for osteoporosis in people with cystic fibrosis. Cochrane Database Syst Rev. 2014. doi: 10.1002/14651858.CD002010.pub3.
  16. Dabrowska E, Błahuszewska K, Minarowska A, et al. Assessment of dental status and oral hygiene in the study population of cystic fibrosis patients in the Podlasie province. Adv Med Sci. 2006;51:100–3.PubMedGoogle Scholar
  17. Davies JC, Alton EW, Bush A. Cystic fibrosis. Brit Med J. 2007;335:1255–9.CrossRefPubMedPubMedCentralGoogle Scholar
  18. Di Sant’Agnese PA, Davis PB. Research in cystic fibrosis (first of three parts). N Engl J Med. 1976;295:481–5.CrossRefPubMedGoogle Scholar
  19. de Oliveira AC, Maluta RP, Stella AE, et al. Isolation of Pseudomonas aeruginosa strains from dental office environments and units in Barretos, state of São Paulo, Brazil, and analysis of their susceptibility to antimicrobial drugs. Braz J Microbiol. 2008;39:579–84.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Döring G, Flume P, Heijerman H, Elborn JS, Consensus Study Group. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros. 2012;11:461–79.CrossRefPubMedGoogle Scholar
  21. Drury D, Grey VL, Ferland G, Gundberg C, Lands LC. Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis. J Cyst Fibros. 2008;7:457–9.CrossRefPubMedGoogle Scholar
  22. Farzal Z, Kou Y-F, St John R, Shah GB, Mitchell RB. The role of routine hearing screening in children with cystic fibrosis on aminoglycosides: a systematic review. Laryngoscope. 2016;126(1):228–35.CrossRefPubMedGoogle Scholar
  23. Fernald GW, Roberts MW, Boat TF. Cystic fibrosis: a current review. Pediatr Dent. 1990;12:72–8.PubMedGoogle Scholar
  24. Ferrazzano GF, Sangianantoni G, Cantile T, et al. Dental enamel defects in Italian children with cystic fibrosis: an observational study. Community Dent Health. 2012;29:106–9.PubMedGoogle Scholar
  25. Fox PC. Differentiation of dry mouth etiology. Adv Dent Res. 1996;10:13–6.CrossRefPubMedGoogle Scholar
  26. Gibson-Corley KN, Meyerholz DK, Engelhardt JF. Pancreatic pathophysiology in cystic fibrosis. J Pathol. 2016;238:311–20.CrossRefPubMedGoogle Scholar
  27. Gysin C, Alothman GA, Papsin BC. Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatr Pulmonol. 2000;30:481–9.CrossRefPubMedGoogle Scholar
  28. Huffmyer JL, Littlewood KE, Nemergut EC. Perioperative management of the adult with cystic fibrosis. Anesth Analg. 2009;109:1949–61.CrossRefPubMedGoogle Scholar
  29. Jagels AE, Sweeney EA. Oral health of patients with cystic fibrosis and their siblings. J Dent Res. 1976;55:991–6.CrossRefPubMedGoogle Scholar
  30. Jensen ET, Giwercman B, Ojeniyi B, et al. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment. J Hosp Infect. 1997;36:117–22.CrossRefPubMedGoogle Scholar
  31. Jones AM, Govan JR, Doherty CJ, et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet. 2001;358:557–8.CrossRefPubMedGoogle Scholar
  32. Kessler WR, Andersen DH. Heat prostration in fibrocystic disease of the pancreas and other conditions. Pediatrics. 1951;8:648–56.PubMedGoogle Scholar
  33. Khasawneh FA, Moti DF, Zorek JA. Linezolid-induced black hairy tongue: a case report. J Med Case Rep. 2013;7:46.CrossRefPubMedPubMedCentralGoogle Scholar
  34. Kinirons MJ. Increased salivary buffering in association with a low caries experience in children suffering from cystic fibrosis. J Dent Res. 1983;62:815–7.CrossRefPubMedGoogle Scholar
  35. Kinirons MJ. Dental health of patients suffering from cystic fibrosis in Northern Ireland. Community Dent Health. 1989;6:113–20.PubMedGoogle Scholar
  36. Kinirons MJ. The effect of antibiotic therapy on the oral health of cystic fibrosis children. Int J Paediatr Dent. 1992;2(3):139–43.CrossRefPubMedGoogle Scholar
  37. Lewis PA, Morison S, Dodge JA, et al. Survival estimates for adults with cystic fibrosis born in the United Kingdom between 1947 and 1967. The UK Cystic Fibrosis Survey Management Committee. Thorax. 1999;54:420–2.CrossRefPubMedPubMedCentralGoogle Scholar
  38. LiPuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet. 1990;336:1094–6.CrossRefPubMedGoogle Scholar
  39. MacDonald A. Nutritional management of cystic fibrosis. Arch Dis Child. 1996;74:81–7.CrossRefPubMedPubMedCentralGoogle Scholar
  40. Mainz JG, Gerber A, Lorenz M, et al. Pseudomonas aeruginosa acquisition in cystic fibrosis patients in context of otorhinolaryngological surgery or dentist attendance: case series and discussion of preventive concepts. Case Rep Infect Dis. 2015. doi: 10.1155/2015/438517.
  41. Mall MA, Galietta LJV. Targeting ion channels in cystic fibrosis. J Cyst Fibros. 2015;14:561–70.CrossRefPubMedGoogle Scholar
  42. Mandel ID, Kutscher A, Denning CR, Thompson RH, Zegarelli EV. Salivary studies in cystic fibrosis. Am J Dis Child. 1967;113:431–8.PubMedGoogle Scholar
  43. Mangos JA, Benke PJ, McSherry NR. Salivary gland enlargement and functional changes during feeding of pancreatin to rats (possible relationship to pathophysiology of cystic fibrosis). J Pediatr. 1969;74:823.CrossRefPubMedGoogle Scholar
  44. Mattsson A. Long-term physical illness in childhood: a challenge to psychosocial adaptation. Pediatrics. 1972;50:801–11.PubMedGoogle Scholar
  45. McCallum TJ, Milunsky JM, Cunningham DL, et al. Fertility in men with cystic fibrosis: an update on current surgical practices and outcomes. Chest. 2000;118:1059–62.CrossRefPubMedGoogle Scholar
  46. Mogayzel PJ, Naureckas ET, Robinson KA, et al. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187:680–9.CrossRefPubMedGoogle Scholar
  47. Molloy L, Nichols K. Infectious diseases pharmacotherapy for children with cystic fibrosis. J Pediatr Health Care. 2015;29:565–78.CrossRefPubMedGoogle Scholar
  48. Moursi AM, Fernandez JB, Daronch M, Zee L, Jones CL. Nutrition and oral health considerations in children with special health care needs: implications for oral health care providers. Pediatr Dent. 2010;32:333–42.PubMedGoogle Scholar
  49. Narang A, Maguire A, Nunn JH, Bush A. Oral health and related factors in cystic fibrosis and other chronic respiratory disorders. Arch Dis Child. 2003;88:702–7.CrossRefPubMedPubMedCentralGoogle Scholar
  50. O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373:1891–904.CrossRefPubMedGoogle Scholar
  51. Plant BJ, Goss CH, Plant WD, Bell SC. Management of comorbidities in older patients with cystic fibrosis. Lancet Respir Med. 2013;1:164–74.CrossRefPubMedGoogle Scholar
  52. Qvist T, Taylor-Robinson D, Waldmann E, et al. Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis. J Cyst Fibros. 2015. doi: 10.1016/j.jcf.2015.09.007.PubMedCentralGoogle Scholar
  53. Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med. 2011;365:1663–72.CrossRefPubMedPubMedCentralGoogle Scholar
  54. Rashid M, Durie P, Andrew M, et al. Prevalence of vitamin K deficiency in cystic fibrosis. Am J Clin Nutr. 1999;70:378–82.PubMedGoogle Scholar
  55. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066–73.CrossRefPubMedGoogle Scholar
  56. Schuster A, Shwachman H. The tetracyclines; applied pharmacology. Pediatr Clin North Am. 1956;3:295–303.Google Scholar
  57. Schwank G, Koo B-K, Sasselli V, et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell. 2013;13:653–8.CrossRefPubMedGoogle Scholar
  58. Scott RB, O’Loughlin EV, Gall DG. Gastroesophageal reflux in patients with cystic fibrosis. J Pediatr. 1985;106:223–7.CrossRefPubMedGoogle Scholar
  59. Sosnay PR, Siklosi KR, Van Goor F, et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet. 2013;45:1160–7.CrossRefPubMedPubMedCentralGoogle Scholar
  60. Stephenson AL, Tom M, Berthiaume Y, et al. A contemporary survival analysis of individuals with cystic fibrosis: a cohort study. Eur Respir J. 2015;45:670–9.CrossRefPubMedGoogle Scholar
  61. Sui W, Boyd C, Wright JT. Altered pH regulation during enamel development in the cystic fibrosis mouse incisor. J Dent Res. 2003;82:388–92.CrossRefPubMedGoogle Scholar
  62. Sweeney EA, Shaw JH. The effect of dietary pancreatin supplements on dental caries and on the composition of saliva in caries-susceptible rats. J Dent Res. 1965;44:973–6.CrossRefPubMedGoogle Scholar
  63. Van Goor F, Hadida S, Grootenhuis PDJ, et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci. 2009;106:18825–30.CrossRefPubMedPubMedCentralGoogle Scholar
  64. Wainwright BJ, Scambler PJ, Schmidtke J, et al. Localization of cystic fibrosis locus to human chromosome 7cen-q22. Nature. 1985;318:384–5.CrossRefPubMedGoogle Scholar
  65. Wiesmann UN, Boat TF, Di Sant’Agnese PA. Flow-rates and electrolytes in minor-salivary-gland saliva in normal subjects and patients with cystic fibrosis. Lancet. 1972;2:510–2.CrossRefPubMedGoogle Scholar
  66. Wotman S, Mercadante J, Mandel ID, Goldman RS, Denning C. The occurrence of calculus in normal children, children with cystic fibrosis, and children with asthma. J Periodontol. 1973;44:278–80.CrossRefPubMedGoogle Scholar

Copyright information

© European Academy of Paediatric Dentistry 2016

Authors and Affiliations

  1. 1.Department of Paediatric DentistryUniversity Dental Hospital ManchesterManchesterUK
  2. 2.University of ManchesterManchesterUK
  3. 3.Manchester Adult Cystic Fibrosis, University Hospital of South ManchesterManchesterUK
  4. 4.Institute of Inflammation and Repair, University of ManchesterManchesterUK

Personalised recommendations